

<!-- XBRL document created with Ez-XBRL version 3.0.1.2  -->
<!-- Based on XBRL 2.1  -->
<xbrli:xbrl xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2011-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:siga="http://www.siga.com/20110930">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="siga-20110930.xsd"/>
<!-- Context Section  -->
<xbrli:context id="Context_As_Of_31-Dec-2009">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_30-Sep-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-07-01
</xbrli:startDate>
<xbrli:endDate>
2010-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_30-Sep-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30-Sep-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_30-Sep-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-07-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_30-Sep-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30-Sep-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_17-Oct-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001010086</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-10-17
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USDPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_9ME_30-Sep-2011">SIGA TECHNOLOGIES INC</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_9ME_30-Sep-2011">0001010086</dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate contextRef="Context_9ME_30-Sep-2011">--12-31</dei:CurrentFiscalYearEndDate>
<dei:EntityFilerCategory contextRef="Context_9ME_30-Sep-2011">Accelerated Filer</dei:EntityFilerCategory>
<dei:TradingSymbol contextRef="Context_9ME_30-Sep-2011">siga</dei:TradingSymbol>
<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of_17-Oct-2011" unitRef="Shares" decimals="0">51418518</dei:EntityCommonStockSharesOutstanding>
<dei:DocumentPeriodEndDate contextRef="Context_9ME_30-Sep-2011">2011-09-30</dei:DocumentPeriodEndDate>
<dei:DocumentType contextRef="Context_9ME_30-Sep-2011">10-Q</dei:DocumentType>
<dei:DocumentFiscalPeriodFocus contextRef="Context_9ME_30-Sep-2011">Q3</dei:DocumentFiscalPeriodFocus>
<dei:DocumentFiscalYearFocus contextRef="Context_9ME_30-Sep-2011">2011</dei:DocumentFiscalYearFocus>
<dei:AmendmentFlag contextRef="Context_9ME_30-Sep-2011">false</dei:AmendmentFlag>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="0">14496313</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30-Sep-2010" unitRef="USD" decimals="0">5711777</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">6332053</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">12409958</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AvailableForSaleSecuritiesCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">14999350</us-gaap:AvailableForSaleSecuritiesCurrent>
<us-gaap:AvailableForSaleSecuritiesCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">0</us-gaap:AvailableForSaleSecuritiesCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">3002144</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">1708294</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">369017</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">420467</us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">24702564</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">14538719</us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">1150257</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">794468</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:Goodwill contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">898334</us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">898334</us-gaap:Goodwill>
<us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNetNoncurrent>
<us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">34180825</us-gaap:DeferredTaxAssetsNetNoncurrent>
<us-gaap:OtherAssetsNoncurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">280648</us-gaap:OtherAssetsNoncurrent>
<us-gaap:OtherAssetsNoncurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">371748</us-gaap:OtherAssetsNoncurrent>
<us-gaap:Assets contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">27031803</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">50784094</us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">2884259</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">2218881</us-gaap:AccountsPayableCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">1378921</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">1476875</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">4263180</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">3695756</us-gaap:LiabilitiesCurrent>
<siga:CommonStockWarrantsNoncurrent xmlns:siga="http://www.siga.com/20110930" contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">10524660</siga:CommonStockWarrantsNoncurrent>

<siga:CommonStockWarrantsNoncurrent xmlns:siga="http://www.siga.com/20110930" contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">1024981</siga:CommonStockWarrantsNoncurrent>

<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">175175</us-gaap:DeferredTaxLiabilitiesNoncurrent>
<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxLiabilitiesNoncurrent>
<us-gaap:OtherLiabilities contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">0</us-gaap:OtherLiabilities>
<us-gaap:OtherLiabilities contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">83699</us-gaap:OtherLiabilities>
<us-gaap:Liabilities contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">14963015</us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">4804436</us-gaap:Liabilities>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">4902</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">5142</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">134524304</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">149087836</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">4067</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">-122464485</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">-103113320</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">12068788</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">45979658</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="0">27031803</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_30-Sep-2011" unitRef="USD" decimals="0">50784094</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Dec-2010" unitRef="USDPerShare" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_30-Sep-2011" unitRef="USDPerShare" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31-Dec-2010" unitRef="Shares" decimals="0">100000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_30-Sep-2011" unitRef="Shares" decimals="0">100000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31-Dec-2010" unitRef="Shares" decimals="0">49019433</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_30-Sep-2011" unitRef="Shares" decimals="0">51418518</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31-Dec-2010" unitRef="Shares" decimals="0">49019433</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_30-Sep-2011" unitRef="Shares" decimals="0">51418518</us-gaap:CommonStockSharesOutstanding>
<siga:ResearchAndDevelopmentRevenue xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">6631857</siga:ResearchAndDevelopmentRevenue>

<siga:ResearchAndDevelopmentRevenue xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">16153821</siga:ResearchAndDevelopmentRevenue>

<siga:ResearchAndDevelopmentRevenue xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">3577948</siga:ResearchAndDevelopmentRevenue>

<siga:ResearchAndDevelopmentRevenue xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">7765725</siga:ResearchAndDevelopmentRevenue>

<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">1389259</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">5591875</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">3968605</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">17569201</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">7419749</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">18176733</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">5170413</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">12572078</us-gaap:ResearchAndDevelopmentExpense>
<siga:PatentPreparationFees xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">234511</siga:PatentPreparationFees>

<siga:PatentPreparationFees xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">860511</siga:PatentPreparationFees>

<siga:PatentPreparationFees xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">482074</siga:PatentPreparationFees>

<siga:PatentPreparationFees xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">1236949</siga:PatentPreparationFees>

<us-gaap:OperatingExpenses contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">9043519</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">24629119</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">9621092</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">31378228</us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">-2411662</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-8475298</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">-6043144</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-23612503</us-gaap:OperatingIncomeLoss>
<siga:ChangeInFairValueOfCommonStockWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">2018644</siga:ChangeInFairValueOfCommonStockWarrants>

<siga:ChangeInFairValueOfCommonStockWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">6142912</siga:ChangeInFairValueOfCommonStockWarrants>

<siga:ChangeInFairValueOfCommonStockWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">-4726054</siga:ChangeInFairValueOfCommonStockWarrants>

<siga:ChangeInFairValueOfCommonStockWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-8528863</siga:ChangeInFairValueOfCommonStockWarrants>

<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">329</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">12429</us-gaap:NonoperatingIncomeExpense>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">-4430306</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-14618210</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">-1316761</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-15071211</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">-1527275</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-34422376</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_30-Sep-2010" unitRef="USD" decimals="0">-4430306</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-14618210</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_30-Sep-2011" unitRef="USD" decimals="0">210514</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">19351165</us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasic contextRef="Context_3ME_30-Sep-2010" unitRef="USDPerShare" decimals="2">-0.10</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_9ME_30-Sep-2010" unitRef="USDPerShare" decimals="2">-0.33</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_3ME_30-Sep-2011" unitRef="USDPerShare" decimals="0">0</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_9ME_30-Sep-2011" unitRef="USDPerShare" decimals="2">0.38</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="Context_3ME_30-Sep-2010" unitRef="USDPerShare" decimals="2">-0.10</us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="Context_9ME_30-Sep-2010" unitRef="USDPerShare" decimals="2">-0.33</us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="Context_3ME_30-Sep-2011" unitRef="USDPerShare" decimals="0">0</us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="Context_9ME_30-Sep-2011" unitRef="USDPerShare" decimals="2">0.20</us-gaap:EarningsPerShareDiluted>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_3ME_30-Sep-2010" unitRef="Shares" decimals="0">45509375</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_9ME_30-Sep-2010" unitRef="Shares" decimals="0">44110885</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_3ME_30-Sep-2011" unitRef="Shares" decimals="0">50806284</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_9ME_30-Sep-2011" unitRef="Shares" decimals="0">50739475</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_3ME_30-Sep-2010" unitRef="Shares" decimals="0">45509375</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_9ME_30-Sep-2010" unitRef="Shares" decimals="0">44110885</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_3ME_30-Sep-2011" unitRef="Shares" decimals="0">51987253</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_9ME_30-Sep-2011" unitRef="Shares" decimals="0">54324977</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:OtherDepreciationAndAmortization contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">463174</us-gaap:OtherDepreciationAndAmortization>
<us-gaap:OtherDepreciationAndAmortization contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">465268</us-gaap:OtherDepreciationAndAmortization>
<siga:IncreaseInFairValueOfWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">6142912</siga:IncreaseInFairValueOfWarrants>

<siga:IncreaseInFairValueOfWarrants xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-8528863</siga:IncreaseInFairValueOfWarrants>

<us-gaap:ShareBasedCompensation contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">1287073</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">10753041</us-gaap:ShareBasedCompensation>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-1044625</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-1293850</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
<us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">7722</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-1203585</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-14926</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-30038</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">91100</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
<us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">34422376</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-1590301</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-567424</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-1357360</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">83699</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-7394464</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">-11655536</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">532996</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">113546</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">17500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">40000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
<us-gaap:PaymentsToAcquireShortTermInvestments contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">26240640</us-gaap:PaymentsToAcquireShortTermInvestments>
<us-gaap:PaymentsToAcquireShortTermInvestments contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">24992928</us-gaap:PaymentsToAcquireShortTermInvestments>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-9273636</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">14893526</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<siga:ProceedsFromIssuanceOfWarrantsAndOptions xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">2383564</siga:ProceedsFromIssuanceOfWarrantsAndOptions>

<siga:ProceedsFromIssuanceOfWarrantsAndOptions xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">3933851</siga:ProceedsFromIssuanceOfWarrantsAndOptions>

<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">5500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">1093936</us-gaap:PaymentsForRepurchaseOfCommonStock>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">7883564</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">2839915</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">-8784536</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">6077905</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<siga:ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2010" unitRef="USD" decimals="0">0</siga:ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise>

<siga:ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011" unitRef="USD" decimals="0">970816</siga:ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise>

<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div align="justify"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;1.&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt; &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;Interim Condensed Consolidated Financial Statements&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) for quarterly reports on Form 10-Q and should be read in conjunction with the Company&amp;#8217;s consolidated audited financial statements and notes thereto for the year ended December 31, 2010, included in the 2010 Annual Report on Form 10-K. All terms used but not defined elsewhere herein have the meaning ascribed to them in the Company&amp;#8217;s 2010 Annual Report on Form 10-K filed on March 9, 2011. In the opinion of management, all adjustments (consisting of normal and recurring adjustments) considered necessary for a fair statement of the results of the interim periods presented have been included. The 2010 year-end balance sheet data was derived from the audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three and nine months ended September 30, 2011 are not necessarily indicative of the results expected for the full year.&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;The accompanying condensed consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has incurred cumulative net losses and expects to incur additional expense to perform further research and development activities. The Company has limited capital resources and will need additional funds to complete the development of our products. Management plans to fund continuing development work and operations through sources of cash that may include: collaborative agreements, strategic alliances, research grants, future equity and debt financing, and procurement contracts. There is no assurance that we will be successful in obtaining future sources of cash on commercially reasonable terms. Management believes that existing funds combined with cash flows primarily from our procurement contract with BARDA (see Note 2) and continuing government grants and contracts will be sufficient to support its operations for at least the next twelve months. As discussed in Note 11, our ability to support our operations&amp;#160;may be adversely&amp;#160;affected by the resolution of a&amp;#160;pending dispute. The success of the Company is dependent upon generating commercial sales and the Company&amp;#8217;s ability to obtain adequate future funding. If the Company is unable to raise adequate capital and/or achieve profitable operations, future operations might need to be scaled back or discontinued. The financial statements do not include any adjustments relating to the recoverability of the carrying amount of recorded assets and liabilities that might result from the outcome of these uncertainties.&lt;/font&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<siga:AdvancedResearchAndDevelopmentAuthorityDisclosureTextBlock xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;2. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;ST-246&amp;#174; BARDA Agreement &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div align="justify"&gt;
&lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;In May 2011, we signed a five-year contract with the U.S. Biomedical Advanced Research and Development Authority (&amp;#8220;BARDA&amp;#8221;), pursuant to which we agreed to deliver two million courses of ST-246 to the U.S. Strategic National Stockpile (&amp;#8220;SNS&amp;#8221;). Under the BARDA Contract, we will sell to BARDA 1.7 million courses of ST-246 and provide other services for a base contract price of approximately $435 million (the BARDA Contract was modified to include certain additional services). SIGA will also contribute to BARDA 300,000 courses of ST-246 manufactured using federal funds provided by the U.S. Department of Health and Human Services (&amp;#8220;HHS&amp;#8221;) under prior development contracts. In addition, the BARDA Contract contains options that, if exercised, will permit us to continue our work on pediatric and geriatric versions of the drug as well as use of ST-246 for smallpox prophylaxis for which we will receive additional consideration. As discussed in Note 11, the amount of consideration we are likely to receive pursuant to the BARDA Contract is dependent upon resolution of a pending dispute.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div align="justify"&gt;
&lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;As originally issued, the BARDA Contract included an option for the purchase of up to 12 million additional courses of ST-246; however, following a protest by a competitor of ours, BARDA issued a contract modification in June 2011 pursuant to which it deleted the option to purchase the additional courses.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</siga:AdvancedResearchAndDevelopmentAuthorityDisclosureTextBlock>

<siga:ResearchAgreementsDisclosureTextBlock xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;3. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Research Agreements &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company obtains funding in the form of grants or contracts (collectively, the &amp;#8220;Grants&amp;#8221;) from various agencies of the U.S. government to support its research and development activities. The Company currently has four active Grants with varying expiration dates through August 2016 that provide for potential future aggregate research and development funding for specific projects of approximately $40 million. This amount includes, among other things, options that may or may not be exercised at the U.S government&amp;#8217;s discretion. The Grants contain customary terms and conditions including the U.S. government&amp;#8217;s right to terminate or restructure a grant for convenience at any time. Since inception, the Company has recognized $11.5 million of revenue from currently active Grants. &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</siga:ResearchAgreementsDisclosureTextBlock>

<us-gaap:EarningsPerShareTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;4. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Per Share Data &lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;The Company computes, presents and discloses earnings per share in accordance with the authoritative guidance, which specifies the computation, presentation and disclosure requirements for earnings per share of entities with publicly held common stock or potential common stock. The objective of basic EPS is to measure the performance of an entity over the reporting period by dividing income (loss) by the weighted average number of shares outstanding. The objective of diluted EPS is consistent with that of basic EPS, except that it also&amp;#160;gives effect to all potentially&amp;#160;dilutive common shares outstanding during the period.&lt;br  /&gt;&lt;br  /&gt;&lt;/font&gt;&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The following is a reconciliation of the basic and diluted net income (loss) per share computations for the periods presented below. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" colspan="6" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Three Months Ended September 30, &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" colspan="6" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Nine Months Ended September 30, &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2010 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2010 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Net income (loss) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;210,514 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(4,430,306 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;19,351,165 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160; (14,618,210 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Change in fair value of warrants &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;8,528,863 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Net income (loss), adjusted for change in &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; fair value of warrants for diluted EPS &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;210,514 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(4,430,306 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;10,822,302 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(14,618,210 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Weighted-average shares - basic &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160; 50,806,284 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;45,509,375 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160; 50,739,475 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;44,110,885 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Effect of potential common shares &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;1,180,970 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;3,585,502 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Weighted-average shares - diluted &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;51,987,254 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160; 45,509,375 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;54,324,977 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;44,110,885 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Earnings (loss) per share - basic &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.00 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(0.10 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.38 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(0.33 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Earnings (loss) per share - diluted &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.00 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(0.10 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.20 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(0.33 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="78%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Anti-dilutive employee share-based&lt;br  /&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; awards, excluded &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;1,812,257 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;9,875,218 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;484,168 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;9,875,218 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;br  /&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;The Company has revised the diluted earnings per share calculation as previously reported for the three and six months ended June 30, 2011 to correctly reflect the effect of the assumed exercise of outstanding warrants and the corresponding elimination of the benefit included in operating results from the change in fair value of the warrants. The revision reduced the numerator used to calculate diluted earnings per share as reported for the change in the fair value of warrants by $2,039,851 and $3,802,809 for the three and six month periods ended June 30, 2011, respectively. The weighted average number of shares outstanding used to compute the revised diluted earnings per share did not change from amounts previously reported. There was no adjustment to basic earnings per share.&lt;/font&gt;&amp;#160; &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left;"&gt;
&lt;table style="line-height: 14pt; width: 90%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="5%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Three Months Ended &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="15%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Six Months Ended &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;June 30, 2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="15%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;June 30, 2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Earnings per share - diluted, as reported &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="4%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.44 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="7%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="8%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.35 &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Earnings per share - diluted, as revised &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="4%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.40 &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="7%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="8%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;0.28 &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;br  /&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Diluted shares outstanding include the dilutive effect of warrants, in-the-money options, unvested restricted stock and restricted stock units. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising stock options, the average amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax benefits that would be recorded in additional paid-in capital when the award becomes deductible, are collectively assumed to be used to repurchase shares. &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
<siga:StockholdersEquityNoteExcludingComprehensiveIncomeDisclosureTextBlock xmlns:siga="http://www.siga.com/20110930" contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;5. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Stockholders&amp;#8217; Equity &lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160; &lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;As of September 30, 2011, the Company&amp;#8217;s authorized share capital consisted of 110,000,000 shares, of which 100,000,000 are designated common shares and 10,000,000 are designated preferred shares. The Company's Board of &lt;/font&gt;Directors is authorized to issue preferred shares in series with rights, privileges and qualifications of each series determined by the Board. &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;In 2006 and 2005 the Company sold shares of its common stock and warrants to purchase shares of common stock. In 2006, the Company issued warrants to acquire 1,000,000 shares of common stock with an initial exercise price of $4.99 per share (the &amp;#8220;2006 Warrants&amp;#8221;). In 2005, the Company issued warrants to acquire 1,000,000 shares of common stock with an initial exercise price of $1.18 per share (the &amp;#8220;2005 Warrants&amp;#8221;). As of December 31, 2010, all of the 2005 Warrants were exercised. The 2006 Warrants may be exercised through and including October 19, 2013. Due to the effect of certain anti-dilution provisions in such warrants, the Company adjusted the number of shares issuable under the 2006 Warrants by 652,038 through September 30, 2011. The exercise prices of the warrants issued in these placements were also adjusted. During the nine months ended September 30, 2011, 100,000 of the 2006 Warrants were exercised. At September 30, 2011, 815,568 of the 2006 Warrants at an exercise price of $2.92 were outstanding. The number of shares issuable pursuant to the warrants may be subject to further adjustment as a result of the effect of future equity issuances on anti-dilution provisions in the related warrant agreements. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company accounted for the 2006 and 2005 Warrants in accordance with the authoritative guidance which requires that free-standing derivative financial instruments that require net cash settlement be classified as assets or liabilities at the time of the transaction, and recorded at their fair value. Any changes in the fair value of the derivative instruments are reported in earnings or loss as long as the derivative contracts are classified as assets or liabilities. At September 30, 2011, the fair market value of the 2006 Warrants was $1.0 million. The Company applied the Black-Scholes model to calculate the fair values of the respective derivative instruments using the contractual term of the warrants. Management estimates the expected volatility using a combination of the Company&amp;#8217;s historical volatility and the volatility of a group of comparable companies. For the nine months ended September 30, 2011, the Company recorded a gain of $8.5 million as a result of a decrease in fair value of the 2006 Warrants. &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</siga:StockholdersEquityNoteExcludingComprehensiveIncomeDisclosureTextBlock>

<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;6. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Comprehensive Income &lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Comprehensive income includes net loss adjusted for the change in net unrealized gain (loss) on short-term investments. For the three and nine months ended September 30, 2011 and 2010, the components of comprehensive income were: &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" colspan="6" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Three Months Ended September 30, &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" colspan="6" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Nine Months Ended September 30, &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2010 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2011 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;2010 &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Net income (loss) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 210,514 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (4,430,306 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 19,351,165 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (14,618,210 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Unrealized gain on securities &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;528 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;- &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;3,889 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1pt solid; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total comprehensive income (loss) &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;210,514 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(4,429,778 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;19,351,165 &lt;/font&gt;&lt;/td&gt;
&lt;td style="background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;$ &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;(14,614,321 &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 2pt double; background-color: #c0c0c0; text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;) &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="text-align: left;" width="79%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
<us-gaap:FairValueDisclosuresTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;7. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Fair Value Measurements &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The carrying value of cash and cash equivalents, accounts payable and accrued expenses approximates fair value due to the relatively short maturity of these instruments. Common stock warrants which are classified as liabilities are recorded at their fair market value as of each reporting period. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company applies the applicable authoritative guidance for financial assets and liabilities that are required to be measured at fair value, and non-financial assets and liabilities that are not required to be measured at fair value on a recurring basis. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The measurement of fair value requires the use of techniques based on observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The inputs create the following fair value hierarchy: &lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;ul style="text-align: justify;"&gt;
&lt;li&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Level 1 &amp;#8211; Quoted prices for identical instruments in active markets.&lt;br  /&gt;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/li&gt;
&lt;li&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Level 2 &amp;#8211; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations where inputs are observable or where significant value drivers are observable.&lt;br  /&gt;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/li&gt;
&lt;li&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Level 3 &amp;#8211; Instruments where significant value drivers are unobservable to third parties.&lt;/font&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company uses model-derived valuations where inputs are observable in active markets to determine the fair value of certain common stock warrants on a recurring basis and classify such warrants in Level 2. The Company utilizes the Black-Scholes model consisting of the following variables: (i) the closing price of SIGA&amp;#8217;s common stock; (ii) the expected remaining life of the warrant; (iii) the expected volatility using a weighted-average of historical volatilities from a combination of SIGA and comparable companies; and (iv) the risk-free market rate. At September 30, 2011 and December 31, 2010, the fair value of such warrants is $1,024,981 and $10,524,660, respectively, and included in long-term liabilities. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;In January 2010, the FASB issued updated accounting guidance for fair value measurements. This update provides amendments that require new disclosure as follows: (1) A reporting entity should disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair-value measurements and describe the reasons for the transfers. (2) In the reconciliation for fair value measurements using significant unobservable inputs (Level 3), a reporting entity should present separately information about purchases, sales, issuances, and settlements (that is, on a gross basis rather than as one net number). This update provides amendments that clarify existing disclosures as follows: (1) A reporting entity should provide fair value measurement disclosures for each class of assets and liabilities. A class is often a subset of assets or liabilities within a line item in the statement of financial position. A reporting entity needs to use judgment in determining the appropriate classes of assets and liabilities. (2) A reporting entity should provide disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements. Those disclosures are required for fair value measurements that fall in either Level 2 or Level 3. The new disclosures and clarifications of existing disclosures were effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll-forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. The Company has adopted the amendments. The adoption did not have a material impact on the condensed consolidated financial statements. &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;8. &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Stock Compensation Plans &lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;In May 2010, the Company adopted its 2010 Incentive Stock Option Plan (the &amp;#8220;2010 Plan&amp;#8221;) to supersede its 1996 Incentive and Non-Qualified Stock Option Plan (the &amp;#8220;1996 Plan&amp;#8221;). The 2010 Plan provides for the granting of up to 2,000,000 shares of the Company&amp;#8217;s common stock to employees, consultants and outside directors of the Company. The awards that may be provided under the 2010 Plan include: incentive stock options, nonqualified stock options, shares of restricted stock and shares of unrestricted stock. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;For the nine months ended September 30, 2011 and 2010, the Company recorded compensation expense of approximately $10.8 million and $1.3 million, respectively, related to employees and directors stock awards. The total fair value of stock options vested during the nine months ended September 30, 2011 and 2010, was approximately $2.3 million &lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;and $1.3 million, respectively. The total fair value of restricted stock and restricted stock units vested during the nine months ended September 30, 2011 and 2010 was approximately $8.5 million and $0, respectively. The total compensation cost not yet recognized related to non-vested awards at September 30, 2011 is $3.1 million. The weighted average period over which total compensation cost is expected to be recognized is 0.9 years. &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div align="justify"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;9.&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt; &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;Income Taxes&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;" size="2"&gt; &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;Deferred tax assets, net were $34.2 million at September 30, 2011 and $0 at December 31, 2010, respectively, net of valuation allowances of $4.2 million and $33.1 million, respectively. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;The Company has incurred losses since inception, which have generated net operating loss carryforwards of approximately $68.7 million at December 31, 2010 for federal and state income tax purposes. These carryforwards are available to offset future taxable income and expire beginning in 2011 for federal income tax purposes. As a result of a previous change in stock ownership, the annual utilization of the net operating loss carryforwards for years prior to 2004 may be subject to limitation.&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;The recognition of a valuation allowance for deferred taxes requires management to make estimates and judgments about the Company&amp;#8217;s future profitability which are inherently uncertain. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;During the nine months ended September 30, 2011, the Company recorded an income tax benefit of $34.4 which included approximately $32.9 million primarily due to a partial reduction of its valuation allowance as a significant portion of its deferred tax assets became realizable on a more-likely-than-not basis as a result of the execution of the BARDA Contract and the resulting forecasts of pre-tax earnings. &lt;font style="display: inline;"&gt;The Company maintains a valuation allowance of $4.2 million with respect to certain net operating losses and other deferred tax assets which may expire prior to realization.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman;" size="2"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;The Company&amp;#8217;s assessment that our deferred tax assets will be realized is based on estimates of future taxable income arising from the BARDA Contract. &amp;#160;If the current estimates of future taxable income are reduced or not realized, for example, based on the ultimate outcome of a pending dispute (see Note 11), our assessment regarding the realization of deferred tax assets could change. &amp;#160;Future changes in the estimated amount of deferred taxes expected to be realized will be reflected in the Company's financial statements in the period the estimate is changed with a corresponding adjustment to operating results. Changes in estimates may occur often and can have a significant favorable or unfavorable impact on the Company's operating results from period to period.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;" size="2"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;" size="2"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;10.&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Related Party Transactions&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div style="text-align: justify;"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;font style="font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;On December 1, 2009, the Company entered into an Office Service Agreement with an affiliate of M&amp;amp;F in order to occupy office space for approximately $8,000 per month. The agreement is cancelable upon 60 days notice by the Company or the affiliate. On June 15, 2011, the Office Service Agreement was amended due to the larger office space used by the Company. This amendment increased the Company&amp;#8217;s monthly payment to $11,000 per month.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;"&gt;&lt;/font&gt;&lt;/font&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;A member of the Company&amp;#8217;s Board of Directors is a member of the Company&amp;#8217;s outside counsel. During the nine months ended September 30, 2011 and 2010, the Company incurred costs of $2.0 million and $1.7 million, respectively, related to services provided by the outside counsel. On September 30, 2011, the Company&amp;#8217;s account payables and accrued expenses included $301,000 to the outside counsel.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_9ME_30-Sep-2011">&lt;div align="justify"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;11.&lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;font style="display: inline; font-weight: bold;"&gt;&lt;font style="font-family: times new roman;"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;In December 2006, PharmAthene, Inc. (&amp;#8220;PharmAthene&amp;#8221;) filed an action against SIGA in the Delaware Court of Chancery (the &amp;#8220;Court&amp;#8221;) captioned &lt;/font&gt;&lt;font style="font-style: italic; display: inline;"&gt;&lt;font style="font-family: times new roman;"&gt;PharmAthene, Inc. v. SIGA Technologies, Inc&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt;., C.A. No. 2627-N. In its amended complaint, PharmAthene asks the Court to order SIGA enter into a license agreement with PharmAthene with respect to ST-246&amp;#174;, as well as issue a declaration that SIGA is obliged to execute such a license agreement, and award damages resulting from SIGA&amp;#8217;s supposed breach of that obligation. PharmAthene also alleges that the Company breached an obligation to negotiate such a license agreement in good faith, as well as seeks damages for promissory estoppel and unjust enrichment based on supposed information, capital and assistance that PharmAthene allegedly provided to SIGA during the negotiation process. In January 2008, the Court of Chancery denied SIGA&amp;#8217;s motion to dismiss the original complaint and discovery proceeded. In May 2009, PharmAthene amended its complaint with respect to its claim for breach of an obligation to negotiate in good faith, and the Company filed our answer to the amended complaint and counterclaim denying the new claim and asserting defenses.&lt;/font&gt;&lt;font style="font-family: times new roman;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company filed a partial summary judgment motion on March 19, 2010, regarding certain aspects of PharmAthene&amp;#8217;s claims and damage assessments. On November 23, 2010, the Court of Chancery denied the motion for partial summary judgment. A trial was held before Vice Chancellor Donald F. Parsons, Jr. in January 2011, and closing arguments took place in April 2011.&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;On September 22, 2011, the Court of Chancery issued its post-trial opinion. The Court denied PharmAthene&amp;#8217;s requests for specific performance and expectation damages measured by the present value of estimated future profits. However, the Court held that SIGA breached its duty to negotiate in good faith and was liable under the doctrine of promissory estoppel. The Court consequently awarded to PharmAthene what the Court described as&lt;font style="display: inline; color: #1f497d;"&gt;&amp;#160;&lt;/font&gt;an equitable payment stream or equitable lien consisting of fifty percent of the net profits that SIGA achieves from sales of ST-246&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#174;&lt;/font&gt; after SIGA has secured the first $40 million in net profits, for ten years following the first commercial sale. In addition, PharmAthene was awarded one-third of its reasonable attorney fees and expert witness expenses.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;SIGA filed a motion for reargument on October 4, 2011, requesting that the Court vacate its award of an equitable payment stream or equitable lien.&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: times new roman, serif; font-size: 10pt;"&gt;The precise amount of payments to be made pursuant to the Court&amp;#8217;s September 2011 ruling remain uncertain. Thus, the Company is unable to estimate a range of loss that may result from the resolution of this matter although such resolution is likely to have a materially adverse&amp;#160;impact unless the motion for reargument is upheld or the Company is successful in any subsequent appeal of the Court&amp;#8217;s final judgment.&lt;br  /&gt;&lt;br  /&gt;&lt;/font&gt;&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;From time to time, the Company is involved in disputes or legal proceedings arising in the ordinary course of business. The Company believes that there is no other dispute or litigation pending that could have, individually or in the aggregate, a material adverse effect on its financial position, results of operations or cash flows. &lt;br  /&gt;&lt;br  /&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-style: italic; display: inline; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Commitments under Operating Leases &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The Company leases certain facilities and office space under operating leases. On June 1, 2011, the Company amended and extended the lease for the laboratory and office facilities space in Corvallis, Oregon. The facilities leased in Corvallis includes space existing under the prior lease terms and newly constructed space in the same building under the most recent lease amendment. &lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;The estimated future minimum noncancelable lease commitments are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="line-height: 14pt; width: 50%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" width="95%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;December 31,&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;2011&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" bgcolor="#c0c0c0" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;81,667&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;2012&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;558,571&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;2013&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" bgcolor="#c0c0c0" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;575,328&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;2014&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;592,588&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;2015&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" bgcolor="#c0c0c0" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;610,366&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" width="95%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;Thereafter&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: #000000 1pt solid;" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman,times; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;1,276,214&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td align="left" bgcolor="#c0c0c0" width="95%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;Total&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: #000000 2pt double;" bgcolor="#c0c0c0" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#c0c0c0" width="3%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-weight: bold; ; font-family: times new roman,times;; font-family:times new roman,times" size="2"&gt;&lt;font style="font-family: times new roman;"&gt;3,694,734&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>

</xbrli:xbrl>